Dermatology Drugs Market Size, Industry Shares, Global Growth and Forecast Report 2030

The global dermatology drugs market attained a value of $25,228.2 million in 2019 and is predicted to generate a revenue of $55,425.0 million by 2030.

According to the estimates of P&S Intelligence, a market research company based in India, the market would progress at a CAGR of 8.8% between 2020 and 2030. The surging geriatric population, the rising prevalence of skin diseases, and the soaring disposable income of people are the main factors driving the progress of the market.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/dermatology-drug-market/report-sample

The growing incidence of skin diseases in various countries is the biggest factor propelling the expansion of the dermatology drugs market across the world. Genetic and environmental factors, trauma, and aging are the main factors responsible for skin ailments. As per the World Health Organization (WHO), nearly 900 million people all over the world suffer from skin diseases at any particular time. Furthermore, skin problems are among the most-prevalent human health diseases across the world.

In the U.S., acne is the most prevalent skin disease and affects as many as 50 million Americans every year. As per the National Eczema Association, in the U.S., 31.6 million people were diagnosed with eczema in 2019. Due to the high prevalence of these diseases, the sales of dermatology drugs are growing rapidly across the globe. Besides this factor, the increasing public awareness of skin diseases is also positively impacting the growth of the dermatology drugs market.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=dermatology-drug-market

Numerous medical product organizations are initiating programs for raising awareness about skin ailments. For example, Kisaco Research conducted Microbiome Connect Skin USA, which is a virtual summit, in June 2020 for recognizing the value of various skin-microbiome-based items as the next step in a person's skincare regimen. Depending on prescription mode, the market is classified into over-the-counter (OTC) drugs and prescription drugs. Between these, the prescription drugs category recorded higher growth in the market in the past.

This was because of the availability of several prescription drugs, the high public preference for consultations with dermatologists, particularly for chronic skin ailments, and the high public awareness about skin problems. When end user is taken into consideration, the dermatology drugs market is classified into clinics, hospitals, cosmetic centers, and at-home settings. Out of these, the cosmetic centers category is predicted to register the fastest growth in the market in the future years.

This would be because of the rising focus of people all over the world on their appearance, the increasing number of cosmetic centers, and highly affordable beauty services provided in these facilities. Globally, the dermatology drugs market is predicted to exhibit the highest growth in North America in the upcoming years, on account of the growing public awareness of skin ailments and their skincare regiment and the existence of several established industry players in the regional countries.

Browse full report at: https://www.psmarketresearch.com/market-analysis/dermatology-drug-market

Thus, it is quite clear that due to the growing prevalence of skin diseases and the increasing public awareness about the treatment of these diseases, the market would register huge expansion across the globe in the coming years.

Dermatology Drugs Market Size Breakdown by Segment

By Treatment
• Topical Corticosteroids
• Retinoids
• Biologics
• Calcineurin Inhibitors
• Antihistamines
• Hormone Therapy
• Others
By Drug
• Humira
• Remicade
• Otezla
• Stelara
• Enbrel
• Cosentyx
• Neoral
• Taltz
• Cubicin
• Canesten
• Zyvox
• Dupixent
• Protopic
• Valtrex
• Eucrisa
• Others
By Prescription Mode
• Prescription Drugs
• Over-the-Counter (OTC) Drugs
By Therapy Area
• Psoriasis
o By prescription mode
• Atopic Dermatitis
o By prescription mode
• Acne
o By prescription mode
• Rosacea
o By prescription mode
• Skin Cancer
o By prescription mode
• Scar
o By prescription mode
By Distribution Channel
• Direct
• Wholesale/retail
• Online
By End User
• Hospitals
• Clinics
• Cosmetic centers
• At-home
• Others

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.